Ossium Health, Inc.
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies (NCT07710781) | Ossium Health, Inc. | 2026-12-01 |
| A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies (NCT05589896) | Ossium Health, Inc. | 2024-08-16 |
| HPC Offered for PRESERVE Expansion (NCT07145411) | Ossium Health, Inc. | 2024-06-27 |
| Mesenchymal Stem Cells (MSCs) for Steroid Refractory Acute GVHD (SR-aGVHD) (NCT05443464) | Ossium Health, Inc. | 2023-06-05 |
| Cryopreserved MMUD BM With PTCy for Hematologic Malignancies (NCT05170828) | Ossium Health, Inc. | 2022-09-01 |
| Mesenchymal Stem Cells (MSCs) for Perianal Fistula (NCT05407766) | Ossium Health, Inc. | 2022-08-01 |
Track Ossium Health, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.